Search clinical trials for: Myocardial Standardized uptake value (SUV)

Total 17841 results

Eli Lilly and Company

Completed

Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Canada
National Center for Complementary and Integrative...

Completed

Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors

Coronary Disease | Diabetes Mellitus, Non-Insulin-Dependent

United States
National Center for Complementary and Integrative...

Completed

Effects of Meditation on Mechanism of Coronary Heart Disease

Coronary Heart Disease

United States
Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada

Unknown

Role of Epicardial Adipose Tissue in Coronary Artery Disease

Coronary Artery Disease | Obesity

Canada
Pfizer

Completed

Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures

Pain
Arginox Pharmaceuticals

Terminated

A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack

Shock, Cardiogenic

United States, Canada
Abbott

Completed

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

Schizophrenia

United States
University of California, San Francisco

Completed

Flushes and Sertraline Trial

Menopause-Hot Flashes

United States
Abbott

Terminated

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

Bipolar Disorder

United States
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
Abarbanel Mental Health Center

Completed

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Israel
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Eli Lilly and Company

Completed

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Schizophrenia

United States, United Kingdom, Spain, Argentina, Mexico, Brazil, Peru, Puerto Rico, Germany, Austria, Ireland, Venezuela
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

Schizophrenia | Schizoaffective Disorder

Australia, Belgium, Brazil, Croatia, Czech Republic, Mexico, Slovakia, Spain
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States
University of Milan

Completed

Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction

Acute Myocardial Infarction | Contrast-Induced Nephropathy

Italy
Acusphere

Completed

Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography

Coronary Artery Disease

United States
Acusphere

Completed

Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging

Coronary Artery Disease

United States
Sheba Medical Center

Unknown

Postconditioning in Primary PCI and Direct Stenting

Myocardial Infarction

Israel
University of Toronto

Unknown

A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina

Chronic Stable Angina

Canada
Rhode Island Hospital
Eli Lilly and Company

Unknown

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
University Hospital, Grenoble

Completed

Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study

Type 1 Diabetes Mellitus

France
Pennsylvania College of Optometry

Completed

A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children

Convergence Insufficiency

United States
University Heart Center Freiburg - Bad Krozingen

Completed

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

Coronary Artery Disease | Drug Resistance

Germany
University of Arizona

Completed

Bupropion Treatment for Youth Smoking Cessation

Nicotine Dependence

United States
PreMD

Completed

Predictor of Advanced Subclinical Atherosclerosis

Coronary Artery Disease

United States
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Completed

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Schizophrenia | Extrapyramidal Syndrome

Taiwan
University of Ulm
Pfizer

Completed

The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia

Coronary Artery Disease | Hypercholesterolemia | Monocyte Function

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Social Anxiety Disorder
NHS Greater Glasgow and Clyde

Unknown

Monitoring Response to Antiplatelet Therapy

Coronary Stenosis | Coronary Thrombosis | Angioplasty, Balloon

United Kingdom
Azienda Sanitaria Ospedaliera
Cardiologia 2 - Emodinamica - Ospedale Maggiore, Novara, Italy

Terminated

Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen

Myocardial Infarction | Coronary Disease

Italy
Kaiser Permanente
Garfield Memorial Fund

Completed

Multidisciplinary Inpatient Palliative Care Intervention

Liver Failure | Acquired Immunodeficiency Syndrome | Stroke | Pneumonia | Diabetes Mellitus | Cancer | Pulmonary Disease, Chronic Obstructive | Respiratory Failure | Renal Failure | Dementia | Kidney Failure, Chronic | Coronary Arteriosclerosis | Cerebrovascular Accident | Failure to Thrive | Heart Failure, Congestive

United States
Royal Perth Hospital
Royal Perth Hospital Medical Research Foundation

Completed

Behavioural Intervention for Dysphagia in Acute Stroke

Dysphagia

Australia
University of Oxford
Sanofi; AstraZeneca

Completed

Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction

Acute Myocardial Infarction

China, United Kingdom
Anesiva, Inc.

Completed

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Coronary Artery Disease

United States
William Beaumont Hospitals
Rhone-Poulenc Rorer

Completed

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

Coronary Artery Disease | Acute Myocardial Infarction

United States

Search clinical trials for: Myocardial Standardized uptake value (SUV)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations